Related Experiment Video
Updated: Aug 7, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Atrial fibrillation and stroke: from scientific evidence to practice
Dominique Deplanque1, Didier Leys
1Department of Pharmacology, Faculty of Medicine, Lille, France. d-deplanque@chru-lille.fr
Abstract:
Nonvalvular atrial fibrillation (NVAF) is the most frequent cause of cardioembolic stroke. Due to the aging of the population, NVAF is becoming an important public health issue. Despite the impressive results of trials with oral anticoagulation (OAC) in primary and secondary prevention of stroke in NVAF patients, OAC remains underused or misused in practice. Beyond the risk of bleeding, there also are several arguments for a lack of knowledge about trials and guidelines. Medical education could then be one of the most effective way to improve stroke prevention in NVAF patients in practice.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Hemorrhagic Stroke ll: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Venous Thrombosis III: Interprofessional Care
Hemorrhagic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology

